Product Description
GSK-256066 is a PDE4B inhibitor which was developed by GlaxoSmithKline and tested in phase II of clinical trials for the treatment of COPD, Asthma and Seasonal allergic rhinitis.Ê (Sourced from: https://drugs.ncats.io/drug/2D6GK059SR)
Mechanisms of Action: PDE4b Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical, Nasal
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: GSK
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Rhinitis, Allergic, Seasonal|Chronic Obstructive Pulmonary Disease|Asthma
Phase 1: Chronic Obstructive Pulmonary Disease
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT00515268 |
IPC103711 | P1 |
Completed |
Chronic Obstructive Pulmonary Disease |
2008-04-23 |
2019-03-21 |
||
NCT00549679 |
IPC101939 | P2 |
Completed |
Chronic Obstructive Pulmonary Disease |
2008-12-15 |
2019-03-22 |
Treatments |
|
NCT00549744 |
IPA107948 | P2 |
Completed |
Asthma |
2008-08-27 |
2019-03-22 |
Treatments |
|
2007-005301-22 |
2007-005301-22 | P2 |
Completed |
Rhinitis, Allergic, Seasonal |
2008-05-26 |
2022-03-12 |
Treatments |
|
2007-005302-44 |
2007-005302-44 | P2 |
Completed |
Rhinitis, Allergic, Seasonal |
2008-05-21 |
2022-03-12 |
Treatments |
|
NCT00612820 |
IPR110723 | P2 |
Completed |
Rhinitis, Allergic, Seasonal |
2008-05-01 |
2019-03-18 |
Treatments |
|
NCT00612118 |
IPR110982 | P2 |
Completed |
Rhinitis, Allergic, Seasonal |
2008-05-01 |
2019-03-18 |
Treatments |
|
2006-006000-11 |
2006-006000-11 | P2 |
Completed |
Rhinitis, Allergic, Seasonal |
2008-02-04 |
2022-03-12 |
Treatments |
|
2005-005339-83 |
2005-005339-83 | P2 |
Completed |
Asthma |
2007-06-20 |
2022-03-12 |
Treatments |
|
NCT00464568 |
IPR109764 | P2 |
Completed |
Rhinitis, Allergic, Seasonal |
2007-05-16 |
2019-03-21 |
Treatments |
|
2006-006710-15 |
2006-006710-15 | P2 |
Completed |
Rhinitis, Allergic, Seasonal |
2007-05-16 |
2022-03-12 |
Treatments |
|
NCT00377728 |
IPR101987 | P2 |
Completed |
Rhinitis, Allergic, Seasonal |
2006-05-01 |
2019-03-21 |
Treatments |
|
NCT00430157 |
IPR107498 | P2 |
Completed |
Rhinitis, Allergic, Seasonal |
None |
2019-03-21 |
Treatments |
|
NCT00445510 |
IPA106620 | P2 |
Completed |
Asthma |
None |
2019-03-21 |
Treatments |
|
NCT00380354 |
IPA101985 | P2 |
Completed |
Asthma |
None |
2019-03-21 |
Treatments |